Doudna, Jennifer A., 1964-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Doudna, Jennifer A.
Jennifer Anne Doudna
داودنا، جنفر، 1964-
דאודנה, ג'ניפר
VIAF ID: 43652981 (Personal)
Permalink: http://viaf.org/viaf/43652981
Preferred Forms
-
100 1 _ ‡a داودنا، جنفر، ‡d 1964-
-
200 _ | ‡a Doudna ‡b Jennifer A. ‡f 1964-....
-
200 _ 1 ‡a Doudna ‡b Jennifer A. ‡f 1964–
-
100 1 _ ‡a Doudna, Jennifer A
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _
‡a
Doudna, Jennifer A.
-
100 1 _
‡a
Doudna, Jennifer A.
-
100 1 _
‡a
Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A.
-
100 1 _ ‡a Doudna, Jennifer A. ‡d (1964- )
-
100 1 _ ‡a Doudna, Jennifer A. ‡d (1964- ).
-
100 1 _
‡a
Doudna, Jennifer A.
‡d
1964-
-
100 1 _ ‡a Doudna, Jennifer A. ‡d 1964-
-
100 1 _
‡a
Doudna, Jennifer A.,
‡d
1964-
-
100 1 _ ‡a Doudna, Jennifer A., ‡d 1964-
-
100 1 _ ‡a Doudna, Jennifer A., ‡d 1964-
-
100 1 _
‡a
Doudna, Jennifer A.,
‡d
1964-
-
100 1 _ ‡a Doudna, Jennifer A., ‡d 1964-
-
100 1 _
‡a
Doudna, Jennifer A.,
‡d
1964-....
-
100 0 _
‡a
Jennifer Anne Doudna
-
100 1 _ ‡a דאודנה, ג'ניפר
-
100 1 _ ‡a داودنا، جنفر، ‡d 1964-
4xx's: Alternate Name Forms (79)
5xx's: Related Names (3)
- 530 _ 0
‡a
A crack in creation
- 500 1 _
‡a
Charpentier, Emmanuelle
‡d
1968-
‡4
bezb
‡4
https://d-nb.info/standards/elementset/gnd#professionalRelationship
‡e
Beziehung beruflich
- 510 2 _
‡a
University of California Berkeley
‡4
affi
‡4
https://d-nb.info/standards/elementset/gnd#affiliation
‡e
Affiliation
Works
| Title | Sources |
|---|---|
| 2016 Tang prize in biopharmaceutical science Emmanuelle Charpenter, Jennifer A. Doudna, Feng Zhang. |
|
| Assunto de: Isaacson, Walter. A decodificadora... 2021 |
|
| Un coup de ciseaux dans la création : CRISPR-Cas9 : le redoutable pouvoir de contrôler l'évolution |
|
| Crack in creation |
|
| CRISPR-Cas a laboratory manual |
|
| Edytorzy genów |
|
| Eingriff in die Evolution die Macht der CRISPR-Technologie und die Frage, wie wir sie nutzen wollen |
|
| Hijacking the ribosome, 2001: |
|
| Jennifer Doudna: We can now edit our DNA. But let's do it wisely |
|
| Kurisupa : Kyukyoku no idenshi henshu gijutsu no hakken. |
|
| Large-scale purification of a stable form of recombinant tobacco etch virus protease |
|
| Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination |
|
| Machine learning predicts new anti-CRISPR proteins |
|
| A magnesium ion core at the heart of a ribozyme domain |
|
| Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation |
|
| Mass spectrometric analysis of the human 40S ribosomal subunit: native and HCV IRES-bound complexes |
|
| Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3 |
|
| Mechanism of ribosome recruitment by hepatitis C IRES RNA |
|
| Mechanism of substrate selection by a highly specific CRISPR endoribonuclease |
|
| Mechanisms of internal ribosome entry in translation initiation |
|
| Molecular biology : principles and practice |
|
| A molecular contortionist |
|
| Molecular mechanism of off-target effects in CRISPR-Cas9 |
|
| Molecular mechanisms of RNA interference |
|
| Multiplexed RNA structure characterization with selective 2'-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-Seq) |
|
| Mutational analysis of conserved nucleotides in a self-splicing group I intron |
|
| n2001128894 |
|
| New CRISPR-Cas systems from uncultivated microbes. |
|
| Nucleic acids and their protein partners |
|
| Nucleosome breathing and remodeling constrain CRISPR-Cas9 function |
|
| Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles |
|
| Optimized High-Throughput Screen for Hepatitis C Virus Translation Inhibitors |
|
| Paul Sigler (1934-2000). |
|
| Perspective: Embryo editing needs scrutiny |
|
| Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity |
|
| A phosphoramidate substrate analog is a competitive inhibitor of the Tetrahymena group I ribozyme |
|
| Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes |
|
| Precise and heritable genome editing in evolutionarily diverse nematodes using TALENs and CRISPR/Cas9 to engineer insertions and deletions |
|
| Preliminary X-ray diffraction studies of an RNA pseudoknot that inhibits HIV-1 reverse transcriptase |
|
| Preparation of homogeneous ribozyme RNA for crystallization |
|
| Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch |
|
| Programmable RNA recognition using a CRISPR-associated Argonaute |
|
| Programmable RNA Tracking in Live Cells with CRISPR/Cas9. |
|
| Programmed DNA destruction by miniature CRISPR-Cas14 enzymes |
|
| Protecting genome integrity during CRISPR immune adaptation |
|
| Quantitative studies of ribosome conformational dynamics |
|
| Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles |
|
| Rapid detection of SARS-CoV-2 with Cas13 |
|
| Rational design of a split-Cas9 enzyme complex |
|
| Reactions to the National Academies/Royal Society Report on Heritable Human Genome Editing |
|
| Real-time observation of DNA recognition and rejection by the RNA-guided endonuclease Cas9. |
|
| Reassortment and mutation of the avian influenza virus polymerase PA subunit overcome species barriers |
|
| Receptor-Mediated Delivery of CRISPR-Cas9 Endonuclease for Cell Type Specific Gene Editing. |
|
| Reconsidering movement of eukaryotic mRNAs between polysomes and P bodies |
|
| Reconstitution of selective HIV-1 RNA packaging in vitro by membrane-bound Gag assemblies |
|
| Reply to Nathamgari et al.: Nanopore electroporation for intracellular delivery of biological macromolecules |
|
| Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression |
|
| Ribonuclease revisited: structural insights into ribonuclease III family enzymes |
|
| Ribozyme catalysis: not different, just worse |
|
| Ribozyme-catalyzed primer extension by trinucleotides: A model for the RNA-catalyzed replication of RNA |
|
| Ribozyme structures and mechanisms |
|
| Ribozymes: the hammerhead swings into action |
|
| RNA-based recognition and targeting: sowing the seeds of specificity |
|
| RNA Binding and HEPN-Nuclease Activation Are Decoupled in CRISPR-Cas13a |
|
| RNA-catalysed synthesis of complementary-strand RNA |
|
| RNA-dependent RNA targeting by CRISPR-Cas9. |
|
| RNA-guided assembly of Rev-RRE nuclear export complexes |
|
| RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions |
|
| RNA-guided genetic silencing systems in bacteria and archaea |
|
| An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3 |
|
| RNA-mediated interaction between the peptide-binding and GTPase domains of the signal recognition particle. |
|
| RNA: primed for packing? |
|
| RNA processing enables predictable programming of gene expression |
|
| RNA-programmed genome editing in human cells |
|
| RNA-protein analysis using a conditional CRISPR nuclease |
|
| RNA Scanning of a Molecular Machine with a Built-in Ruler |
|
| RNA seeing double: Close-packing of helices in RNA tertiary structure |
|
| RNA structure: crystal clear? |
|
| A sparse matrix approach to crystallizing ribozymes and RNA motifs |
|
| A Unified Resource for Tracking Anti-CRISPR Names |
|
| A universal mode of helix packing in RNA. |
|
| An unusual case of pseudo-merohedral twinning in orthorhombic crystals of Dicer |
|
| The use of CRISPR/Cas9, ZFNs and TALENs in generating site-specific genome alterations |
|
| クリスパーCRISPR : 究極の遺伝子編集技術の発見 |
|
| 人類が進化する未来 : 世界の科学者が考えていること |
|
